Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreas Adenocarcinoma · Borderline Resectable Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Study coordinator · ahumbert@wakehealth.edu · 336-713-6912
Contact: Principal Investigator (Ravi K Paluri, MD, MPH)

Study leads

Ravi K Paluri, MD, MPH
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Adenocarcinoma · Carcinoma · Neoplasms

Abroad (travel likely)Recruiting

Béthune, France · Bordeaux, France

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Pancreas Cancer · Pancreas Neoplasm · Pancreas Disease

Abroad (travel likely)Recruiting

Umeå, Sweden

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Kochi, Japan